Abstract:Background β-Nicotinamide mononucleotide (NMN) is the direct precursor of nicotinamide coenzymes such as NAD + and NADP + , which are widely applied in industrial biocatalysis especially involving cofactor-dependent oxidoreductases. Moreover, NMN is a promising candidate for medical uses since it is considered to be beneficial for improving health of aged people who usually suffer from an insufficient level of NAD + . To date, various methods have been developed for the synthesis of NMN. Chemical phosphorylation of nicotinamide riboside (NR) to NMN depends on excessive phosphine oxychloride and delicate temperature control, while fermentation of NMN is limited by low product titers, making it unsuitable for industrial-scale NMN production. As a result, the more efficient synthesis process of NMN is still challenging. Aim This work attempted to construct an eco-friendly and cost-effective biocatalytic process for transforming the chemically synthesized NR into the highly value-added NMN. Results A new nicotinamide riboside kinase ( Klm- NRK) was identified from Kluyveromyces marxianus . The specific activity of purified Klm- NRK was 7.9 U·mg –1 protein, ranking the highest record among the reported NRKs. The optimal pH of Klm -NRK was 7.0 in potassium phosphate buffer. The purified Klm -NRK retained a half activity after 7.29 h at 50 °C. The catalytic efficiencies ( k cat / K M ) toward ATP and nicotinamide riboside (NR) were 57.4 s −1 ·mM −1 and 84.4 s −1 ·mM −1 , respectively. In the presence of an external ATP regeneration system (AcK/AcP), as much as 100 g·L –1 of NR could be completely phosphorylated to NMN in 8 h with Klm -NRK, achieving a molar isolation yield of 84.2% and a space–time yield of 281 g·L −1 ·day −1 . These inspiring results indicated that Klm -NRK is a promising biocatalyst which provides an efficient approach for the bio-manufacturing of NMN in a high titer. Graphical Abstract

Synthesis of Β-Nicotinamide Riboside Using an Efficient Two-Step Methodology.

Metabolic Engineering of Bacillus licheniformis for the Bioproduction of Nicotinamide Riboside from Nicotinamide and Glucose

Enzymatic Synthesis of High-Titer Nicotinamide Mononucleotide with a New Nicotinamide Riboside Kinase and an Efficient ATP Regeneration System

Improvement of an enzymatic cascade synthesis of nicotinamide mononucleotide via protein engineering and reaction-process reinforcement

Recent Advances in the Chemical Synthesis of β-Nicotinamide Mononucleotide

Structure-guided mining and engineering of nicotinamide riboside kinase for efficient synthesis of nicotinamide mononucleotide

Synthesis of Phosphodiester-Type Nicotinamide Adenine Dinucleotide Analogs

Biosynthesis of β-nicotinamide mononucleotide from glucose via a new pathway in Bacillus subtilis

Enhanced Production of Β-Nicotinamide Mononucleotide with Exogenous Nicotinamide Addition in Saccharomyces Boulardii-Ys01.

Biosynthesis of Nicotinamide Mononucleotide: Current Metabolic Engineering Strategies, Challenges, and Prospects

Design and tailoring of an artificial DNA scaffolding system for efficient production of nicotinamide mononucleotide

Systematic Engineering of Escherichia coli for Efficient Production of Nicotinamide Mononucleotide From Nicotinamide

Gram-scale Biocatalytic Preparation of the Non-Natural Cofactor Nicotinamide Cytosine Dinucleotide

Whole-cell synthesis of nicotinamide mononucleotide by recombinant Saccharomyces cerevisiae from glucose and nicotinamide

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells

NRH Salvage and Conversion to NAD+ Requires NRH Kinase Activity by Adenosine Kinase.

Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm

Synthesis of NMN by cascade catalysis of intracellular multiple enzymes

Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives

High-Level Production of Nicotinamide Mononucleotide by Engineered Escherichia Coli.

Biocatalytic Synthesis of Ribonucleoside Analogues Using Nucleoside Transglycosylase-2